Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method of Using FOXO3A Polymorphisms and Haplotypes to Predict and Promote Healthy Aging and Longevity

a technology of foxo3a and polymorphisms, applied in the field of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity, can solve the problems of disappointing studies of candidate genes in humans, hereafter referred to as “longevity genes,” and achieve the effect of wide spread of human aging phenotypes and longevity, and maximum coverage of each gen

Inactive Publication Date: 2011-09-01
KUAKINI MEDICAL CENT
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The patent text describes a method for identifying a specific gene, FOXO3A, that has a significant impact on human longevity and health. The method involves analyzing the DNA of individuals and identifying specific patterns of the gene that are associated with increased or decreased likelihood of living longer or developing age-related diseases. This information can be used to develop personalized healthcare programs for individuals, as well as to develop new pharmaceutical treatments for age-related diseases. The method can also be used in veterinary medicine to analyze the gene in animals and predict which ones would benefit from certain treatments. Overall, the patent provides a valuable tool for identifying and studying genes that affect human longevity and health."

Problems solved by technology

For example, family studies of nonagenarians and centenarians show that sibling relative risk, a common method for assessing potential genetic contribution to a complex phenotype,6 is particularly high and grows with increasing age of the proband.7-10 However, studies of candidate “longevity-associated” genes in humans, hereafter referred to as “longevity genes,” have generally been disappointing.
Human longevity, however, is a complex phenotype that encompasses disease-specific risks as well as the individual rate of aging.
The study of its genetic antecedents is challenging.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of Using FOXO3A Polymorphisms and Haplotypes to Predict and Promote Healthy Aging and Longevity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

A. Hawaii Lifespan Study

Study Population

[0029]This nested-case control study was conducted as part of the Hawaii Lifespan Study, an embedded cohort study of healthy aging drawn from the original population of the Honolulu Heart Program (HHP) and Honolulu Asia Aging Study (HAAS). The HHP is a population-based, prospective study of cardiovascular disease among 8,006 Japanese American men that began in 1965. The HHP participants were recruited from 9,877 men with valid contact information who were born between 1900 and 1919 and lived on the island of Oahu in 1965.61

[0030]Study participants had both parents from Japan, usually the west and southern parts of Japan (94% from the central region or further west and south); 49% of them had parental origins from the adjacent prefectures of Hiroshima and Yamaguchi.61,62 Although the most participants were born in Hawaii (88%), there is a theoretical possibility of confounding of case control status with allele frequencies due to geographic or...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
physical functionaaaaaaaaaa
sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides methods and compositions relating to identification and use of genetic information from the FOXO3A gene that can be used for determining and increasing an individual's likelihood of longevity and of retaining physical and cognitive function during aging, and for determining and decreasing an individual's likelihood of developing a cardiovascular-, metabolic- or age-related disease, including coronary artery (heart) disease, stroke, cancer, chronic pulmonary disease, diabetes, Parkinson's disease and dementia.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application is in part based on, and claims the benefit of U.S. Provisional Patent Application No. 61 / 087,722, filed Aug. 10, 2008, which is incorporated herein by reference.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]This invention was made with government support under grant 1 R01 AG027060-01 (Defining the Healthy Aging Phenotype) from the National Institute on Aging. Additional funding was provided by U.S. government support under contract N01-HC-05102 from the National Heart, Lung, and Blood Institute, contract N01-AG-4-2149 and grants 5 U01 AG019349-05 and K08 AG22788-02 from the National Institute on Aging. The U.S. government has certain rights in the invention. Additional support came under grant 2004-0463 from the Hawaii Community Foundation.FIELD OF INVENTION[0003]The invention relates to a method of using FOXO3A polymorphisms and haplotypes in diagnostics to predict or in planning treatments and int...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68C12Q1/02
CPCC12Q1/6883C12Q2535/125C12Q1/6876C12Q2600/172C12Q2600/158C12Q2600/156G01N33/15C12Q2600/106
Inventor DONLON, TIMOTHY ATCHISONWILLCOX, BRADLEY JOHNCURB, J. DAVID
Owner KUAKINI MEDICAL CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com